2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
EM Cronin, FM Bogun, P Maury, P Peichl, M Chen… - EP …, 2019 - academic.oup.com
Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …
variety of forms, from single premature ventricular complexes to sustained ventricular …
Management of arrhythmias in heart failure
Heart failure patients are predisposed to develop arrhythmias. Supraventricular arrhythmias
can exacerbate the heart failure symptoms by decreasing the effective cardiac output and …
can exacerbate the heart failure symptoms by decreasing the effective cardiac output and …
Myocardial lesion size after epicardial electroporation catheter ablation after subxiphoid puncture
K Neven, V van Driel, H van Wessel… - Circulation …, 2014 - Am Heart Assoc
Background—Irreversible electroporation is a promising nonthermal ablation modality able
to create deep myocardial lesions. We investigated lesion size after epicardial …
to create deep myocardial lesions. We investigated lesion size after epicardial …
Impact of electrode type on map** of scar‐related VT
Map** of Scar‐Related VT Background Substrate‐based VT ablation is mostly based on
maps acquired with ablation catheters. We hypothesized that multipolar map** catheters …
maps acquired with ablation catheters. We hypothesized that multipolar map** catheters …
Arrhythmogenic right ventricular cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of
conditions characterized by right ventricular fibrofatty infiltration, with a predominant …
conditions characterized by right ventricular fibrofatty infiltration, with a predominant …
Substrate map** and ablation for ventricular tachycardia: the LAVA approach
F Sacher, HS Lim, N Derval, A Denis… - Journal of …, 2015 - Wiley Online Library
Substrate Map** and Ablation Introduction Catheter ablation of ventricular tachycardia
(VT) is proven effective therapy particularly in patients with frequent defibrillator shocks …
(VT) is proven effective therapy particularly in patients with frequent defibrillator shocks …
Infarct transmurality as a criterion for first-line endo-epicardial substrate–guided ventricular tachycardia ablation in ischemic cardiomyopathy
J Acosta, J Fernández-Armenta, D Penela, D Andreu… - Heart Rhythm, 2016 - Elsevier
Background There is no consensus on the appropriate indications for the epicardial
approach in substrate ablation of post–myocardial infarction (MI) ventricular tachycardia …
approach in substrate ablation of post–myocardial infarction (MI) ventricular tachycardia …
Ventricular tachycardia ablation in nonischemic cardiomyopathy
K Zeppenfeld - JACC: Clinical Electrophysiology, 2018 - jacc.org
Catheter ablation is being increasingly performed as adjunctive treatment to prevent
recurrent implantable cardioverter-defibrillator therapies in patients with nonischemic …
recurrent implantable cardioverter-defibrillator therapies in patients with nonischemic …
Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: results from a multicenter study
Background The comparative efficacy of antiarrhythmic drug (AAD) therapy vs ventricular
tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is …
tachycardia (VT) ablation in arrhythmogenic right ventricular cardiomyopathy (ARVC) is …
Ultralow temperature cryoablation: safety and efficacy of preclinical atrial and ventricular lesions
F Bourier, M Takigawa, A Lam… - Journal of …, 2021 - Wiley Online Library
Background Ultralow temperature cyroablation (ULTC) is designed to create focal, linear,
and circumferential lesions. The aim of this study was to assess the safety, efficacy, and …
and circumferential lesions. The aim of this study was to assess the safety, efficacy, and …